Your search for “Vita Capital II Ltd”

Swiss Re has entered into a transaction with Vita Capital II Ltd to receive up to USD 362 million of payments in the event of severe population mortality. Swiss Re experienced strong interest in the life catastrophe bond, which was oversubscribed. The structure of the Vita Capital II risk coverage is based on a combined […]

Swiss Re has transferred $705 million (denominated in USD and Euros) of extreme mortality risk to the capital markets through its Vita Capital securitisation programme. Swiss Re experienced strong interest in this, its third mortality catastrophe bond, which has been issued privately to institutional investors. Part of the issuance will be used to replace cover […]

Aetna, the health, medical and benefits insurer unit of CVS Health, is back in the insurance-linked securities (ILS) market to sponsor a fourteenth Vitality Re health insurance catastrophe bond issuance, targeting $200m of reinsurance from a Vitality Re XIV Ltd (Series 2023) transaction. For 2023, we’re told that Aetna has registered a new Cayman Islands […]

Aetna, the health and medical insurance arm of CVS Health, is back in the capital market with another insurance-linked security (ILS) issuance, targeting issuance of what will be its thirteenth sponsorship of a Vitality Re health insurance catastrophe bond structure, aiming to secure $200m of reinsurance from a Vitality Re XIII Ltd. transaction. For 2022, […]

Aetna has returned to the capital markets and insurance-linked securities (ILS) with what will be its twelfth sponsorship of a Vitality Re health insurance catastrophe bond structure, with a targeted $200m Vitality Re XII Ltd. transaction. For 2021, Aetna has registered a new Cayman Islands company as the issuer, Vitality Re XII Limited. Vitality Re […]

This deal entry refers to four series of notes issued by Vita Capital IV. Series I, II, III, IV. The first two Vita Capital IV tranches of mortality catastrophe bond notes, Series I and Series II used a trigger derived from the risk of an increase in age and gender-weighted mortality rates that exceeds a […]

Vitality Re II Ltd. is a Cayman Islands domiciled SPV set up for Health Re Inc. and ultimately Aetna Life Insurance Co. to transfer medical benefit claims risks to capital markets investors. The deal provides them with a source of indemnity based on an annual aggregate excess of loss reinsurance basis for medical benefit claims […]

Aetna are returning to the ILS market to secure another $150m of coverage for increases in their medical benefit claims ratio. A similar deal to the earlier Vitality transactions, Vitality Re III Ltd. see’s them try to achieve funding for Vitality Re III’s (a Cayman Islands SPV) commitments under excess of loss agreements with Health […]

Vitality Re V Ltd. sees life and health insurer Aetna once again using its captive Health Re Inc. as the ceding reinsurer for this transaction, with the protection ultimately reinsuring the health insurance portfolio of its Aetna Life Insurance Company subsidiary. Two tranches of notes are being issued, with a preliminary total deal size of […]

This is Aetna’s sixth Vitality Re medical benefit ratio linked ILS deal. The series of transactions protect Aetna on a reinsurance basis against sudden rises in health insurance medical benefit claims and the insurer has effectively been using them as a capital tool, freeing up capital while also acquiring protection against unexpected or sharp increases […]

Latest Monte Carlo Rendezvous Reinsurance news: Interview – Why ILS managers are staying firm on rates: Michael Stahel, LGT September 26th, 2016 – Michael Stahel, Partner and Portfolio Manager at LGT ILS Partners describes how tearing down the wall between the reinsurance and capital markets has fundamentally altered the reinsurance cycle. Interview – Unwillingness to pay “one […]